Public Reporting

Name and Location
USMM Accountable Care Partners
500 Kirts Blvd.
Troy, MI 48084

 

Primary Contact
Joan Valentine, RN, MSA
Email: jvalentine@usmmllc.com
Phone: 248-434-6222

ACO Participants

ACO Participant in Joint Venture   (Enter Y or N)

VPA of Texas PLLC

N

RMED LLC

N

VPA PC

N

 

Member

Member's Voting Power –Expressed as a percentage or number

Membership Type -

ACO Participant Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Smith

Michael

Chairman

1

ACO Participant Representative

RMed, LLC

Valentine

Joan

Vice Chairman

1

ACO Participant Representative

VPA, P.C.

Del Pilar

Erlinda

Voting Member

1

ACO Participant Representative

VPA of Texas, PLLC

Schroeder

Stuart

Treasurer

1

ACO Participant Representative

VPA, P.C.

Olsen

Stephanie

Secretary

1

ACO Participant Representative

VPA, P.C.

Daly

Annemarie

Voting Member

1

ACO Participant Representative

VPA, P.C.

Sagritalo

Ronald

Voting Member

1

ACO Participant Representative

VPA, P.C.

Patel

Bhavesh

Voting Member

1

ACO Participant Representative

RMed, LLC

Beatty

Lynn

Voting Member

1

ACO Participant Representative

VPA, P.C.

Pappas

Ann

Voting Member

1

Medicare Beneficiary Representative

N/A

Key ACO Clinical and Administrative Leadership

  • Joan Valentine - ACO Executive
  • Annemarie Daly- Medical Director
  • Ron Sagritalo- Compliance Officer
  • Joan Valentine - Quality Assurance/Improvement Officer
  • Care Management - Jennifer Powell, V.P. Medical Management
  • Quality Management & Peer Review - Joan Valentine, Exec V.P., VPA
  • Finance- Stuart Schroeder, CFO
  • Compliance - Ron Sagritalo, Chief Compliance Officer

 Networks of individual practices of ACO professionals

 

Amount of Shared Savings/Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2017, $20,750,377
    • Performance Year 2016, $21,195,787
    • Performance Year 2015, $7,393,855

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2017
      • Proportion invested in infrastructure: 14%
      • Proportion invested in redesigned care processes/resources: 67%
      • Proportion of distribution to ACO participants: 19%
    • Performance Year 2016
      • Proportion invested in infrastructure: 13%
      • Proportion invested in redesigned care processes/resources: 68%
      • Proportion of distribution to ACO participants: 19%
    • Performance Year 2015
      • Proportion invested in infrastructure: 60%
      • Proportion invested in redesigned care processes/resources: 15%
      • Proportion of distribution to ACO participants: 25%

 

2017 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

77.85

80.60

ACO-2

CAHPS: How Well Your Providers Communicate

87.57

93.13

ACO-3

CAHPS: Patients’ Rating of Provider

85.79

92.31

ACO-4

CAHPS: Access to Specialists

81.43

83.32

ACO-5

CAHPS: Health Promotion and Education

61.62

62.30

ACO-6

CAHPS: Shared Decision Making

72.98

75.85

ACO-7

CAHPS: Health Status/Functional Status

50.58

73.05

ACO-34

CAHPS: Stewardship of Patient Resources

30.74

25.68

ACO-8

Risk Standardized, All Condition Readmission

15.77

15.01

ACO-35

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

17.62

18.46

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

80.05

79.16

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

66.91

61.74

ACO-43

Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))

2.51

1.93

ACO-11

Use of Certified EHR Technology

100.00

98.48

ACO-12

Medication Reconciliation

100.00

75.32

ACO-13

Falls: Screening for Future Fall Risk

88.46

74.38

ACO-44

Imaging Studies for Low Back Pain

65.29

67.32

ACO-14

Preventive Care and Screening: Influenza Immunization

86.94

72.52

ACO-15

Pneumonia Vaccination Status for Older Adults

66.53

72.92

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up

75.97

70.69

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

98.06

90.48

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

89.08

61.98

ACO-19

Colorectal Cancer Screening

34.41

64.58

ACO-20

Breast Cancer Screening

24.60

70.05

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

75.46

79.89

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

18.55

16.74

ACO-41

Diabetes: Eye Exam

25.00

50.37

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

69.89

71.47

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

88.32

86.86

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples and the ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes quality measure is not included in public reporting due to a non-material technical error.

 

Note: In the Quality Performance Results file(s) above, search for “USMM ACCOUNTABLE CARE PARTNERS, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A2671 in the public use files on data.cms.gov.